CBD and nutra sell through the same channels, carry the same “high-risk” flag, and get quoted the same punishing rates. Then one gets approved in a week and the other gets terminated in a quarter. The label hides the real story: these two verticals fail underwriting for opposite reasons.
CBD fails on paperwork and legality optics. Nutra fails on how it bills. Fix the wrong one and you are still cash-only, or worse, on the MATCH list.
CBD is a documentation problem, not a legal one
Hemp-derived CBD has been federally legal since the 2018 Farm Bill drew the line at 0.3% delta-9 THC. Banks know that. They still treat it as a liability because proving compliance sits with you, transaction by transaction. Visa classifies hemp CBD as high-risk and often wants the merchant registered under its Integrity Risk Program and coded to the right MCC, typically 5912 or 5499. Miscode it and the account gets pulled.
What underwriters actually want is boring and specific: a current Certificate of Analysis from an accredited third-party lab for every SKU, a website scrubbed of health claims and testimonials that read as medical advice, an FDA disclaimer, and published refund and shipping policies. Bring that and approval runs about 5 to 10 business days; our step-by-step checklist for getting a CBD merchant account approved walks through every document. Skip it and you get declined, not negotiated with.
CBD gets declined on paperwork. Nutra gets terminated on disputes.
Nutra is a billing problem the FTC just made murkier
Supplements clear the legality bar easily. They fail on the business model. Free trials, auto-ship, and continuity billing are the engine of nutra revenue and the source of its chargebacks: the customer forgets the trial converts, sees a charge they do not recognise, and calls the issuer instead of the merchant. Dispute ratios climb, and the card networks do not care why.
Here is the trap merchants are walking into in 2026. The FTC’s “click to cancel” negative-option rule, which would have forced easy online cancellation, was vacated by the Eighth Circuit in July 2025 on procedural grounds. The agency has restarted rulemaking, with comments due in April 2026. Plenty of operators read the headline as “the cancellation rule is dead” and relaxed.
Warning
Do not relax. The FTC rule being vacated changes nothing about your merchant account. ROSCA still applies, state auto-renewal laws still apply, and Visa and Mastercard enforce their own free-trial and cancellation-disclosure rules regardless of what the FTC does. Your acquirer answers to the schemes, not the Eighth Circuit.
The controls that keep a nutra account alive are the same ones the vacated rule would have required anyway: clear trial terms at checkout, a reminder email before the first real charge, and a one-click cancel. Merchants who ship those see disputes fall. The ones betting on the rule staying dead watch their VAMP ratio drift toward the 1.5% excessive line and their reserve climb.
| Vertical | Why it is flagged | What underwriters check | First thing to fix |
|---|---|---|---|
| CBD / hemp | Legality optics, THC liability | COA per SKU, correct MCC, no health claims | Certificates of Analysis and clean site copy |
| Nutra / supplements | Dispute-heavy billing | Trial terms, cancel flow, chargeback ratio | Pre-billing reminder and one-click cancel |
The through-line: pick a specialist, prep before you apply
For both verticals, the fastest way to a frozen account is applying to Stripe, Square, or PayPal, which tolerate neither and pull funds the moment they notice. A true high-risk acquirer will underwrite you, but only after you have done the work: the CBD lab reports and compliant copy, or the nutra billing controls. Expect an initial monthly cap around $25k to $100k while the processor builds your risk profile, then negotiate the reserve down once your history is clean.
The mistake is treating “high-risk” as one problem with one solution. CBD and nutra break in different places, so they need different fixes. Diagnose which one you are before you fill in a single application.
- Vector Payments, “The Ultimate Guide to CBD Payments,” vectorpayments.com, 2026.
- Payment Nerds, “CBD Merchant Account Guide 2026,” paymentnerds.com, 2026.
- Payment Nerds, “Nutraceutical and Supplement Merchant Account 2026,” paymentnerds.com, 2026.
- Merchant Risk Council, “Stricter VAMP Ratio Thresholds Are Now in Effect,” merchantriskcouncil.org, 2026.
- Mayer Brown, “Click-to-Cancelled! Eighth Circuit Vacates the FTC’s Revised Negative Option Rule,” mayerbrown.com, July 2025.
- Gibson Dunn, “FTC Restarts Negative Option Rulemaking After Eighth Circuit Vacatur,” gibsondunn.com, 2026.
